Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients.
about
How We Read Oncologic FDG PET/CT18F-FDG PET as novel imaging biomarker for disease progression after ablation therapy in colorectal liver metastases.EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program.Anatomical Grading for Metabolic Activity of Brown Adipose Tissue.Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data.EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.Point-spread function reconstructed PET images of sub-centimeter lesions are not quantitative.Clinical evaluation of (18)F-fludeoxyglucose positron emission tomography/CT using point spread function reconstruction for nodal staging of colorectal cancerUsing PET for therapy monitoring in oncological clinical trials: challenges ahead.Validation of phantom-based harmonization for patient harmonization.Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET.Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs)Metabolic Tumor Volume in Lymphoma: Hype or Hope?Characteristics of Smoothing Filters to Achieve the Guideline Recommended Positron Emission Tomography Image without Harmonization.18F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer.Interim PET in lymphoma: from Deauville to Peking criteria. On the road, again….Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC.Multicentre analysis of PET SUV using vendor-neutral software: the Japanese Harmonization Technology (J-Hart) study
P2860
Q28066962-9215CA25-564E-49DE-BAEA-1757CF744525Q33695043-59C8DAE9-61C4-4900-BE84-4627A4A2EA3AQ33740261-214757D4-5DDA-41B3-A357-3B2138F6058EQ35930982-01997C24-9A76-47F8-93FC-4D33624C4FBCQ36282168-1FFADB17-129A-49CD-9F3C-CA7B25079C8DQ37433290-75EB4788-7E1C-4D98-8C3E-3EB647190B38Q37586025-6331F0AE-BE0C-42FA-B575-6A1426F45C06Q37600880-C3680C08-5B7D-4292-B998-5CB9429CD950Q38689940-4A6D0CF9-DACF-4CC0-BC15-540A4EE16E22Q38808641-1DFC9923-9742-4475-81EB-7256649AC897Q39216200-E2F63C0D-A8BE-4E89-A3D1-55A520D90C12Q39422071-5DA78AA9-79A7-4C22-A5F2-2F1B770C67CCQ42097286-B07EA7C1-704C-4E94-AE02-25CB9E83422CQ42696218-AB4C218D-6A23-4D5E-A2BE-1992802D5065Q47563435-39ABAAEF-118A-4156-8290-F47759987A8CQ48248991-4BACF075-AF69-4C54-9A3D-A12FAF2BA135Q50276035-E579E36A-FD64-4C88-A49A-DBFD34E5BF9EQ50499472-24993752-1DC9-41A8-BF8A-1A2A836A3ACAQ58765546-EDE2B0CC-906C-4609-92E7-99F2DBDF13B2
P2860
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Harmonizing FDG PET quantifica ...... tion in 517 oncology patients.
@ast
Harmonizing FDG PET quantifica ...... tion in 517 oncology patients.
@en
type
label
Harmonizing FDG PET quantifica ...... tion in 517 oncology patients.
@ast
Harmonizing FDG PET quantifica ...... tion in 517 oncology patients.
@en
prefLabel
Harmonizing FDG PET quantifica ...... tion in 517 oncology patients.
@ast
Harmonizing FDG PET quantifica ...... tion in 517 oncology patients.
@en
P2093
P2860
P50
P1476
Harmonizing FDG PET quantifica ...... tion in 517 oncology patients.
@en
P2093
Cédric Desmonts
David Bourhis
Elske Quak
Jason Callahan
Michael S Hofman
Philippe Robin
P2860
P2888
P304
P356
10.1007/S00259-015-3128-0
P577
2015-07-30T00:00:00Z